
Kimberly Chong
Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1636, 1635, 1674 |
| Total Applications | 2007 |
| Issued Applications | 1153 |
| Pending Applications | 209 |
| Abandoned Applications | 674 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5385686
[patent_doc_number] => 20090226931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'DUAL-TARGET BIOSENSOR CELL ASSAYS'
[patent_app_type] => utility
[patent_app_number] => 12/388685
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13415
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226931.pdf
[firstpage_image] =>[orig_patent_app_number] => 12388685
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/388685 | Dual-target biosensor cell assays | Feb 18, 2009 | Issued |
Array
(
[id] => 6102704
[patent_doc_number] => 20110166197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'Antisense Modulation Of Amyloid Beta Protein Expression'
[patent_app_type] => utility
[patent_app_number] => 12/918402
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18067
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166197.pdf
[firstpage_image] =>[orig_patent_app_number] => 12918402
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918402 | Antisense Modulation Of Amyloid Beta Protein Expression | Feb 18, 2009 | Abandoned |
Array
(
[id] => 5985492
[patent_doc_number] => 20110097721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'IN VIVO GENE SENSORS'
[patent_app_type] => utility
[patent_app_number] => 12/867537
[patent_app_country] => US
[patent_app_date] => 2009-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18978
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097721.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867537
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867537 | In vivo gene sensors | Feb 16, 2009 | Issued |
Array
(
[id] => 5929956
[patent_doc_number] => 20110039915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'IMMUNOSTIMULATORY siRNA MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 12/867656
[patent_app_country] => US
[patent_app_date] => 2009-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15439
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039915.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867656
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867656 | Immunostimulatory siRNA molecules | Feb 15, 2009 | Issued |
Array
(
[id] => 5392315
[patent_doc_number] => 20090209628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'MULTIPLE RNAi EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS RELATED TO HETEROZYGOTIC EXPRESSION PATTERNS'
[patent_app_type] => utility
[patent_app_number] => 12/371211
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10908
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209628.pdf
[firstpage_image] =>[orig_patent_app_number] => 12371211
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/371211 | MULTIPLE RNAi EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS RELATED TO HETEROZYGOTIC EXPRESSION PATTERNS | Feb 12, 2009 | Abandoned |
Array
(
[id] => 7561864
[patent_doc_number] => 20110275697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'REGULATION OF CYCLIN D'
[patent_app_type] => utility
[patent_app_number] => 12/735738
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17573
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275697.pdf
[firstpage_image] =>[orig_patent_app_number] => 12735738
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/735738 | REGULATION OF CYCLIN D | Feb 11, 2009 | Abandoned |
Array
(
[id] => 5954496
[patent_doc_number] => 20110034537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD45 GENE'
[patent_app_type] => utility
[patent_app_number] => 12/867230
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 26053
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034537.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867230
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867230 | Compositions and methods for inhibiting expression of CD45 gene | Feb 11, 2009 | Issued |
Array
(
[id] => 5392313
[patent_doc_number] => 20090209626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Duplex Oligonucleotides with Enhanced Functionality in Gene Regulation'
[patent_app_type] => utility
[patent_app_number] => 12/368856
[patent_app_country] => US
[patent_app_date] => 2009-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15792
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209626.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368856
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368856 | Duplex oligonucleotides with enhanced functionality in gene regulation | Feb 9, 2009 | Issued |
Array
(
[id] => 8340167
[patent_doc_number] => 08242092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-14
[patent_title] => 'Protein tyrosine phosphatase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/366562
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23085
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12366562
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/366562 | Protein tyrosine phosphatase inhibitors | Feb 4, 2009 | Issued |
Array
(
[id] => 5380279
[patent_doc_number] => 20090192118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'TAK1-D MEDIATED INDUCTION OF CELL DEATH IN HUMAN CANCER CELLS BY SPECIFIC SEQUENCE SHORT DOUBLE-STRANDED RNAS'
[patent_app_type] => utility
[patent_app_number] => 12/361311
[patent_app_country] => US
[patent_app_date] => 2009-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 30118
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192118.pdf
[firstpage_image] =>[orig_patent_app_number] => 12361311
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/361311 | TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS | Jan 27, 2009 | Issued |
Array
(
[id] => 5532950
[patent_doc_number] => 20090232738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity'
[patent_app_type] => utility
[patent_app_number] => 12/319991
[patent_app_country] => US
[patent_app_date] => 2009-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 43387
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232738.pdf
[firstpage_image] =>[orig_patent_app_number] => 12319991
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/319991 | Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity | Jan 13, 2009 | Issued |
Array
(
[id] => 5552983
[patent_doc_number] => 20090286969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs'
[patent_app_type] => utility
[patent_app_number] => 12/345811
[patent_app_country] => US
[patent_app_date] => 2008-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 136597
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286969.pdf
[firstpage_image] =>[orig_patent_app_number] => 12345811
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/345811 | Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs | Dec 29, 2008 | Abandoned |
Array
(
[id] => 6486022
[patent_doc_number] => 20100285484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'APOPTOSIS INDUCING POSITIVE CONTROL FOR EXPRESSION MODULATION EXPERIMENTS'
[patent_app_type] => utility
[patent_app_number] => 12/810281
[patent_app_country] => US
[patent_app_date] => 2008-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7292
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285484.pdf
[firstpage_image] =>[orig_patent_app_number] => 12810281
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810281 | Apoptosis inducing positive control for expression modulation experiments | Dec 28, 2008 | Issued |
Array
(
[id] => 5570394
[patent_doc_number] => 20090253772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF CXCR4 GENE EXPRESSION USING SHORT INTERFERING NUCELEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/334163
[patent_app_country] => US
[patent_app_date] => 2008-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 59946
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253772.pdf
[firstpage_image] =>[orig_patent_app_number] => 12334163
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/334163 | RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA) | Dec 11, 2008 | Issued |
Array
(
[id] => 6265326
[patent_doc_number] => 20100297750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'POLYNUCLEOTIDE OR ANALOGUE THEREOF, AND GENE EXPRESSION REGULATION METHOD USING THE POLYNUCLEOTIDE OR THE ANALOGUE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/812444
[patent_app_country] => US
[patent_app_date] => 2008-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13446
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297750.pdf
[firstpage_image] =>[orig_patent_app_number] => 12812444
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/812444 | POLYNUCLEOTIDE OR ANALOGUE THEREOF, AND GENE EXPRESSION REGULATION METHOD USING THE POLYNUCLEOTIDE OR THE ANALOGUE THEREOF | Dec 3, 2008 | Abandoned |
Array
(
[id] => 8549486
[patent_doc_number] => 08324369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Dendritic cell vaccine compositions and uses of same'
[patent_app_type] => utility
[patent_app_number] => 12/744651
[patent_app_country] => US
[patent_app_date] => 2008-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 49
[patent_no_of_words] => 36315
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12744651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744651 | Dendritic cell vaccine compositions and uses of same | Nov 25, 2008 | Issued |
Array
(
[id] => 6186331
[patent_doc_number] => 20110124591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'COMPOUNDS AND METHODS FOR MODULATING PROTEIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/742652
[patent_app_country] => US
[patent_app_date] => 2008-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17291
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124591.pdf
[firstpage_image] =>[orig_patent_app_number] => 12742652
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742652 | Compounds and methods for modulating protein expression | Nov 12, 2008 | Issued |
Array
(
[id] => 7801244
[patent_doc_number] => 08129516
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-03-06
[patent_title] => 'RNA complexes featuring paranemic binding, methods of their production and sensors and analytical methods involving same'
[patent_app_type] => utility
[patent_app_number] => 12/291697
[patent_app_country] => US
[patent_app_date] => 2008-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8557
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/129/08129516.pdf
[firstpage_image] =>[orig_patent_app_number] => 12291697
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/291697 | RNA complexes featuring paranemic binding, methods of their production and sensors and analytical methods involving same | Nov 12, 2008 | Issued |
Array
(
[id] => 8982096
[patent_doc_number] => 08513209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair'
[patent_app_type] => utility
[patent_app_number] => 12/742233
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24055
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12742233
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742233 | Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair | Nov 9, 2008 | Issued |
Array
(
[id] => 5546662
[patent_doc_number] => 20090156539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'ANTISENSE OLIGONUCLEOTIDES (ODN) AGAINST SMAD7 AND USES THEREOF IN MEDICAL FIELD'
[patent_app_type] => utility
[patent_app_number] => 12/264058
[patent_app_country] => US
[patent_app_date] => 2008-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12925
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156539.pdf
[firstpage_image] =>[orig_patent_app_number] => 12264058
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/264058 | Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field | Nov 2, 2008 | Issued |